We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-14.3%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$85.3B
AUM Growth
-$21.5B
Cap. Flow
-$8.24B
Cap. Flow %
-9.67%
Top 10 Hldgs %
8.52%
Holding
6,080
New
596
Increased
1,780
Reduced
1,836
Closed
791

Sector Composition

Rank Sector Weight
1 Technology 12.38%
2 Financials 10.31%
3 Healthcare 7.77%
4 Consumer Discretionary 7.11%
5 Industrials 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROCAR
4701
DELISTED
ROC Energy Acquisition Corp. Rights
ROCAR
$43K ﹤0.01%
266,667
AHRNW
4702
DELISTED
Ahren Acquisition Corp Warrants
AHRNW
$43K ﹤0.01%
303,751
+203,751
+204% +$53.1K
RRAC.WS
4703
DELISTED
Rigel Resource Acquisition Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RRAC.WS
$42K ﹤0.01%
199,999
CNGLW
4704
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
$42K ﹤0.01%
525,000
GENQW
4705
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$42K ﹤0.01%
+310,000
New +$49.8K
NGC.WS
4706
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$42K ﹤0.01%
126,627
LYLT
4707
PUT
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$42K ﹤0.01%
11,640
OPFI.WS
4708
DELISTED
OppFi Inc Warrants
OPFI.WS
$41K ﹤0.01%
+127,516
New +$45.1K
ITAQW
4709
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
$41K ﹤0.01%
274,999
+183,333
+200% +$36.5K
EVLO
4710
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$41K ﹤0.01%
960
-187
-16% -$8.67K
PCXCW
4711
DELISTED
Parsec Capital Acquisitions Corp Warrant
PCXCW
$41K ﹤0.01%
281,900
VSEEW
4712
VSee Health Warrant
VSEEW
$248K
$40K ﹤0.01%
365,000
SLAMW
4713
DELISTED
Slam Corp. warrant
SLAMW
$40K ﹤0.01%
159,816
CONXW
4714
DELISTED
CONX Corp. Warrant
CONXW
$40K ﹤0.01%
250,000
GOGN.WS
4715
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$40K ﹤0.01%
166,666
SPCMW
4716
DELISTED
Sound Point Acquisition Corp I, Ltd Warrant
SPCMW
$40K ﹤0.01%
+250,000
New +$49K
BYNOW
4717
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$39K ﹤0.01%
+371,250
New +$62.3K
SHAP.WS
4718
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$39K ﹤0.01%
325,000
+216,667
+200% +$38.9K
APGB.WS
4719
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$39K ﹤0.01%
156,051
TOACW
4720
DELISTED
Talon 1 Acquisition Corp. Warrant
TOACW
$39K ﹤0.01%
262,500
GROV.WS
4721
DELISTED
Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50
GROV.WS
$39K ﹤0.01%
+93,074
New +$46.7K
DNA.WS
4722
DELISTED
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
$38K ﹤0.01%
71,236
VCXB.WS
4723
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$38K ﹤0.01%
375,000
+250,000
+200% +$42.6K
HCMAW
4724
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$38K ﹤0.01%
375,000
+250,000
+200% +$43.3K
CLVR
4725
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$38K ﹤0.01%
+1,311
New +$52.3K

Similar funds

D.E. Shaw & Co's Q2 2022 Portfolio in Review

As of Q2 2022, D.E. Shaw & Co held 6,080 positions worth $85.3B, down 20% from $107B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.

D.E. Shaw & Co withdrew a net $8.24B in Q2 2022, closing 791 positions and reducing 1,836 holdings. Its most notable exit was Dominion Energy, Inc. 2019 Series A Corporate Units, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in iShares MSCI Emerging Markets ETF worth $171M.

  • D.E. Shaw & Co's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 4,273,656 shares worth $171M.
  • D.E. Shaw & Co added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2022, an estimated $510M increase.
  • D.E. Shaw & Co's biggest Q2 2022 reduction was Marathon Petroleum, cutting an estimated $573M.
  • D.E. Shaw & Co fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q2 2022, selling an estimated $64.1M.
  • D.E. Shaw & Co's ten largest holdings make up 8.5% of its $85.3B portfolio in Q2 2022.
  • D.E. Shaw & Co opened 596 new positions and closed 791 in Q2 2022.
  • D.E. Shaw & Co's portfolio value fell 20% quarter-over-quarter to $85.3B.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.